U.S. Nanomedicine Market Size & Outlook, 2023-2030
U.S. nanomedicine market, 2018-2030 (US$M)
Related Markets
U.S. nanomedicine market highlights
- The U.S. nanomedicine market generated a revenue of USD 91,158.6 million in 2023 and is expected to reach USD 199,562.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.8% from 2024 to 2030.
- In terms of segment, drug delivery was the largest revenue generating application in 2023.
- Therapeutics is the most lucrative application segment registering the fastest growth during the forecast period.
Nanomedicine market data book summary
| Market revenue in 2023 | USD 91,158.6 million |
| Market revenue in 2030 | USD 199,562.7 million |
| Growth rate | 11.8% (CAGR from 2023 to 2030) |
| Largest segment | Drug delivery |
| Fastest growing segment | Therapeutics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Delivery, Therapeutics, In-vitro Diagnostics, Implants, In-vivo Imaging |
| Key market players worldwide | Abbott Laboratories, Invitae Corp, Celgene, GE HealthCare Technologies Inc Common Stock, Johnson & Johnson, Mallinckrodt PLC Ordinary Shares - New, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Arrowhead Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 47.8% of the global nanomedicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. nanomedicine market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 12,836.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nanomedicine Market Scope
Nanomedicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. nanomedicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nanomedicine market will help companies and investors design strategic landscapes.
Drug delivery was the largest segment with a revenue share of 34.09% in 2023. Horizon Databook has segmented the U.S. nanomedicine market based on drug delivery, therapeutics, in-vitro diagnostics, implants, in-vivo imaging covering the revenue growth of each sub-segment from 2018 to 2030.
Furthermore, presence of organizations involved in conducting conferences and workshop for growing awareness about the application of nanoscience in therapeutic development is expected to accelerate the market growth in this country in the coming years.
For instance, American Society for Nanomedicine is involved in conducting quarterly conferences on nanoscience and nanomedicine.
Reasons to subscribe to U.S. nanomedicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. nanomedicine market databook
-
Our clientele includes a mix of nanomedicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. nanomedicine market , including forecasts for subscribers. This country databook contains high-level insights into U.S. nanomedicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. nanomedicine market size, by application, 2018-2030 (US$M)
U.S. Nanomedicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
